315 related articles for article (PubMed ID: 11069595)
1. Effects of eletriptan on the peptidergic innervation of the cerebral dura mater and trigeminal ganglion, and on the expression of c-fos and c-jun in the trigeminal complex of the rat in an experimental migraine model.
Knyihár-Csillik E; Tajti J; Csillik AE; Chadaide Z; Mihály A; Vécsei L
Eur J Neurosci; 2000 Nov; 12(11):3991-4002. PubMed ID: 11069595
[TBL] [Abstract][Full Text] [Related]
2. Effect of a serotonin agonist (sumatriptan) on the peptidergic innervation of the rat cerebral dura mater and on the expression of c-fos in the caudal trigeminal nucleus in an experimental migraine model.
Knyihár-Csillik E; Tajti J; Samsam M; Sáry G; Slezák S; Vécsei L
J Neurosci Res; 1997 Jun; 48(5):449-64. PubMed ID: 9185668
[TBL] [Abstract][Full Text] [Related]
3. Functional immunohistochemistry of neuropeptides and nitric oxide synthase in the nerve fibers of the supratentorial dura mater in an experimental migraine model.
Knyihár-Csillik E; Tajti J; Chadaide Z; Csillik B; Vécsei L
Microsc Res Tech; 2001 May; 53(3):193-211. PubMed ID: 11301495
[TBL] [Abstract][Full Text] [Related]
4. The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist.
Gupta P; Butler P; Shepperson NB; McHarg A
Eur J Pharmacol; 2000 Jun; 398(1):73-81. PubMed ID: 10856450
[TBL] [Abstract][Full Text] [Related]
5. Electrical stimulation of the Gasserian ganglion induces structural alterations of calcitonin gene-related peptide-immunoreactive perivascular sensory nerve terminals in the rat cerebral dura mater: a possible model of migraine headache.
Knyihar-Csillik E; Tajti J; Mohtasham S; Sari G; Vecsei L
Neurosci Lett; 1995 Jan; 184(3):189-92. PubMed ID: 7715843
[TBL] [Abstract][Full Text] [Related]
6. mRNA expression of 5-hydroxytryptamine 1B, 1D, and 1F receptors and their role in controlling the release of calcitonin gene-related peptide in the rat trigeminovascular system.
Amrutkar DV; Ploug KB; Hay-Schmidt A; Porreca F; Olesen J; Jansen-Olesen I
Pain; 2012 Apr; 153(4):830-838. PubMed ID: 22305629
[TBL] [Abstract][Full Text] [Related]
7. Colocalization of CGRP with 5-HT1B/1D receptors and substance P in trigeminal ganglion neurons in rats.
Ma QP; Hill R; Sirinathsinghji D
Eur J Neurosci; 2001 Jun; 13(11):2099-104. PubMed ID: 11422450
[TBL] [Abstract][Full Text] [Related]
8. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine.
Buzzi MG; Moskowitz MA
Cephalalgia; 1991 Sep; 11(4):165-8. PubMed ID: 1660351
[TBL] [Abstract][Full Text] [Related]
9. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
Knight YE; Edvinsson L; Goadsby PJ
Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
[TBL] [Abstract][Full Text] [Related]
10. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.
Hoskin KL; Goadsby PJ
Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of low dose CP122,288 and eletriptan on fos expression due to stimulation of the superior sagittal sinus in cat.
Goadsby PJ; Hoskin KL
Pain; 1999 Jul; 82(1):15-22. PubMed ID: 10422655
[TBL] [Abstract][Full Text] [Related]
12. The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation.
Gupta P; Brown D; Butler P; Ellis P; Grayson KL; Land GC; Macor JE; Robson SF; Wythes MJ; Shepperson NB
Br J Pharmacol; 1995 Nov; 116(5):2385-90. PubMed ID: 8581273
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in Dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats.
Shepheard SL; Williamson DJ; Williams J; Hill RG; Hargreaves RJ
Neuropharmacology; 1995 Mar; 34(3):255-61. PubMed ID: 7630480
[TBL] [Abstract][Full Text] [Related]
14. Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist.
Cumberbatch MJ; Williamson DJ; Mason GS; Hill RG; Hargreaves RJ
Br J Pharmacol; 1999 Mar; 126(6):1478-86. PubMed ID: 10217543
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
[TBL] [Abstract][Full Text] [Related]
16. Salmon calcitonin ameliorates migraine pain through modulation of CGRP release and dural mast cell degranulation in rats.
Kilinc E; Dagistan Y; Kukner A; Yilmaz B; Agus S; Soyler G; Tore F
Clin Exp Pharmacol Physiol; 2018 Jun; 45(6):536-546. PubMed ID: 29344989
[TBL] [Abstract][Full Text] [Related]
17. Different trigemino-vascular responsiveness between adolescent and adult rats in a migraine model.
Fan PC; Kuo PH; Hu JW; Chang SH; Hsieh ST; Chiou LC
Cephalalgia; 2012 Oct; 32(13):979-90. PubMed ID: 22843221
[TBL] [Abstract][Full Text] [Related]
18. Suppression by eletriptan of the activation of trigeminovascular sensory neurons by glyceryl trinitrate.
Lambert GA; Boers PM; Hoskin KL; Donaldson C; Zagami AS
Brain Res; 2002 Oct; 953(1-2):181-8. PubMed ID: 12384251
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological, pharmacokinetic and clinical profile of eletriptan (Relpax), a new triptan for migraine].
Omote M
Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):93-101. PubMed ID: 12843576
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine.
Messlinger K; Fischer MJ; Lennerz JK
Keio J Med; 2011; 60(3):82-9. PubMed ID: 21979827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]